2 Sources
[1]
QT Imaging Announces Second Quarter 2024 Financial Results
QT Imaging Holdings, Inc. (NASDAQ: QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024. "QT Imaging's team completed the first
[2]
Kopin Corporation Reports Financial Results for the Second Quarter 2024
Kopin Corporation (Nasdaq: KOPN), a leading provider of application-specific optical solutions and high-performance microdisplays for defense, enterprise, consumer, and medical products, today reported financial results for the second quarter ended June 29, 2024. Commenting on the quarterly
Share
Copy Link
QT Imaging Holdings Inc. and Kopin Corporation, two technology companies in different sectors, have released their financial results for the second quarter of 2024. Both companies show progress in their respective fields but face ongoing challenges.

QT Imaging Holdings Inc., a medical imaging technology company, has reported its financial results for the second quarter of 2024. The company, known for its QT Ultrasound Breast Scanner, showed significant progress in various areas
1
.Revenue for the quarter reached $1.1 million, marking a substantial increase from $0.2 million in the same period last year. This growth is attributed to the rising adoption of the company's innovative breast imaging technology. The gross profit also saw an improvement, rising to $0.5 million from $0.1 million year-over-year
1
.Despite these positive indicators, QT Imaging still faces challenges. The company reported a net loss of $3.6 million for the quarter, although this represents an improvement from the $4.5 million loss in Q2 2023. Operating expenses increased to $4.1 million, up from $3.4 million in the previous year, reflecting ongoing investments in research and development
1
.Kopin Corporation, a leading provider of application-specific optical solutions and high-performance micro-displays, also released its financial results for the second quarter of 2024
2
.The company reported total revenues of $10.5 million for Q2 2024, a slight decrease from $10.6 million in the same period of 2023. Product revenues showed a marginal increase to $6.1 million, up from $6.0 million year-over-year. However, funded research and development revenues decreased to $4.4 million from $4.6 million
2
.Kopin's gross margin saw an improvement, rising to 44% from 25% in Q2 2023. This increase was primarily due to a more favorable product mix and improved manufacturing efficiencies. The company's net loss narrowed significantly to $2.9 million, compared to $6.2 million in the same quarter last year
2
.Related Stories
Both QT Imaging and Kopin Corporation's results reflect the ongoing challenges and opportunities in their respective tech sectors. QT Imaging's revenue growth suggests increasing market acceptance of its ultrasound technology in breast imaging, potentially disrupting traditional methods. However, the company's continued losses indicate the need for further market penetration and cost management
1
.Kopin's results demonstrate the company's ability to maintain relatively stable revenues in a challenging market environment. The improved gross margin and reduced net loss suggest effective cost control measures and a shift towards higher-margin products. The company's focus on micro-displays for augmented and virtual reality applications positions it well in the growing wearable technology market
2
.As both companies continue to innovate and adapt to market demands, their performance in the coming quarters will be crucial in determining their long-term success and impact on their respective industries.
Summarized by
Navi
[1]
[2]
1
Policy and Regulation

2
Technology

3
Technology
